Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
40
CVV.V Quote, Financials, Valuation and Earnings
Last price:
$0.88
Seasonality move
:
22.03%
Day range:
$0.78 - $0.88
52-week range:
$0.51 - $1.26
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.07x
Volume:
511.5K
Avg. volume:
778.7K
1-year change:
-1.12%
Market cap:
$193.4M
Revenue:
--
EPS (TTM):
-$0.09
Analysts' Opinion
-
Consensus RatingCanAlaska Uranium Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $0.87, CanAlaska Uranium Ltd. has an estimated downside of -1.03% from its current price of $0.88.
-
Price Target UpsideAccording to analysts, the highest upside price target is $1.06 representing 20.15% upside increase from its current price of $0.88.
Fair Value
-
According to the consensus of 3 analysts, CanAlaska Uranium Ltd. has -1.03% downside to fair value with a price target of $0.87 per share.
CVV.V vs. S&P 500
-
Over the past 5 trading days, CanAlaska Uranium Ltd. has overperformed the S&P 500 by 2.31% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
CanAlaska Uranium Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CanAlaska Uranium Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter CanAlaska Uranium Ltd. reported revenues of --.
Earnings Growth
-
CanAlaska Uranium Ltd. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter CanAlaska Uranium Ltd. reported earnings per share of -$0.02.
Enterprise value:
156.8M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.14x
EV / Free cash flow:
-10.46x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$181K
Return On Assets:
-61.91%
Net Income Margin (TTM):
--
Return On Equity:
-74.84%
Return On Invested Capital:
-72.53%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$199K | -$188K | -$181K | -$45K | -$44K | |
| Operating Income | -$14.2M | -$9.5M | -$20.1M | -$1.3M | -$3.5M | |
| EBITDA | -$14M | -$9.3M | -$20M | -$1.2M | -$3.5M | |
| Diluted EPS | -$0.09 | -$0.05 | -$0.09 | -$0.01 | -$0.02 | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $12.9M | $15.4M | $8.5M | $15.1M | $37.6M | |
| Total Assets | $13.9M | $16.9M | $11.3M | $16.4M | $38.9M | |
| Current Liabilities | $367K | $483K | $1.3M | $866K | $6.5M | |
| Total Liabilities | $641K | $1.1M | $2M | $1.5M | $7M | |
| Total Equity | $13.3M | $15.8M | $9.3M | $15M | $31.9M | |
| Total Debt | $334K | $715K | $804K | $713K | $630K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-10-31 | 2024-10-31 | 2025-10-31 | 2024-10-31 | 2025-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$11.6M | -$12.5M | -$14.9M | -$2.8M | -$4.9M | |
| Cash From Investing | -$339K | -$84K | $315K | $274K | -$12K | |
| Cash From Financing | $7.3M | $17.9M | $36.7M | $5.7M | $19.9M | |
| Free Cash Flow | -$12M | -$12.6M | -$15M | -$2.8M | -$4.9M | |
CVV.V
Sector
Market Cap
$193.4M
$37.3M
Price % of 52-Week High
70.12%
76.07%
Dividend Yield
0%
0%
Shareholder Yield
-18.7%
0.03%
1-Year Price Total Return
-1.12%
--
Beta (5-Year)
2.212
0.426
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.85
200-day SMA
Buy
Level
$0.83
Bollinger Bands (100)
Buy
Level
0.61 - 0.97
Chaikin Money Flow
Sell
Level
-2.9M
20-day SMA
Buy
Level
$0.84
Relative Strength Index (RSI14)
Buy
Level
56.39
ADX Line
Sell
Level
18.02
Williams %R
Neutral
Level
-50
50-day SMA
Buy
Level
$0.71
MACD (12, 26)
Buy
Level
0.23
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Sell
Level
-4.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (23.3688)
Sell
CA Score
(Annual)
Level (-1.948)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (6.7663)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CanAlaska Uranium Ltd. is an exploration stage company, which engages in the exploration and acquisition of uranium, nickel, and diamond properties. It focuses on West McArthur, Moon Lake South, Key Extension, Waterbury South, and Cree East projects. The company was founded on May 22, 1985 and is headquartered in Saskatoon, Canada.
Stock Forecast FAQ
In the current month, CVV.V has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CVV.V average analyst price target in the past 3 months is $0.87.
-
Where Will CanAlaska Uranium Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that CanAlaska Uranium Ltd. share price will drop to $0.87 per share over the next 12 months.
-
What Do Analysts Say About CanAlaska Uranium Ltd.?
Analysts are divided on their view about CanAlaska Uranium Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CanAlaska Uranium Ltd. is a Sell and believe this share price will rise from its current level to $0.72.
-
What Is CanAlaska Uranium Ltd.'s Price Target?
The price target for CanAlaska Uranium Ltd. over the next 1-year time period is forecast to be $0.87 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CVV.V A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CanAlaska Uranium Ltd. is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CVV.V?
You can purchase shares of CanAlaska Uranium Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CanAlaska Uranium Ltd. shares.
-
What Is The CanAlaska Uranium Ltd. Share Price Today?
CanAlaska Uranium Ltd. was last trading at $0.88 per share. This represents the most recent stock quote for CanAlaska Uranium Ltd.. Yesterday, CanAlaska Uranium Ltd. closed at $0.88 per share.
-
How To Buy CanAlaska Uranium Ltd. Stock Online?
In order to purchase CanAlaska Uranium Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CVV.V Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CVV.V
Sector
P/E ratio
--
13.38x
PEG ratio
-0.14x
0.00x
P/B ratio
6.07x
1.03x
Price / LTM sales
--
1.02x
Growth Metrics
CVV.V
Sector
Revenue growth
--
-3.81%
Earnings growth
-183.61%
-12.5%
Revenue (5-year growth)
--
5.58%
Earnings forecast
--
$0.17
Profitability
CVV.V
Sector
Profitability FY 2025
-$183K
$14.2M
Return on invested capital
-72.53%
1.78%
Return on assets
-61.91%
0.22%
Return on equity
-74.84%
3.2%
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Feb
10
Estimated Next Earnings Date
May
12
Balance Sheet
CVV.V
Sector
Total cash
$37.3M
$9.8M
Short term investments
$1.8M
$2.2M
Total assets
$23.1M
$268.8M
Long term debt
$630K
$12.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
84
VAL alert for Feb 10
Valaris Ltd. [VAL] is up 34.18% over the past day.
Sell
18
MNDY alert for Feb 10
monday.com Ltd. [MNDY] is down 20.77% over the past day.
Buy
69
GDXU alert for Feb 10
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 17.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
